BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

529 related articles for article (PubMed ID: 10999820)

  • 1. Primary hyperaldosteronism without suppressed renin due to secondary hypertensive kidney damage.
    Oelkers W; Diederich S; Bähr V
    J Clin Endocrinol Metab; 2000 Sep; 85(9):3266-70. PubMed ID: 10999820
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Normokalemic hyperaldosteronism in patients with resistant hypertension.
    Benchetrit S; Bernheim J; Podjarny E
    Isr Med Assoc J; 2002 Jan; 4(1):17-20. PubMed ID: 11802302
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Rectal electrical potential difference and plasma aldosterone in hyperaldosteronism and low-, normal- and high-renin hypertension].
    Skrabal F; Mauser R
    Wien Klin Wochenschr; 1976 Dec; 88(23):777-81. PubMed ID: 1014711
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The aldosterone/renin ratio as a screening test for primary aldosteronism.
    Rayner BL; Opie LH; Davidson JS
    S Afr Med J; 2000 Apr; 90(4):394-400. PubMed ID: 10957926
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Renin-angiotensin-aldosterone system in arterial hypertension.
    Horký K; Gregorová I
    Cor Vasa; 1980; 22(1-2):59-73. PubMed ID: 6995018
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The spironolactone, amiloride, losartan, and thiazide (SALT) double-blind crossover trial in patients with low-renin hypertension and elevated aldosterone-renin ratio.
    Hood SJ; Taylor KP; Ashby MJ; Brown MJ
    Circulation; 2007 Jul; 116(3):268-75. PubMed ID: 17606839
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Primary hyperaldosteronism due to adrenal microadenoma: a curable cause of refractory hypertension.
    Myint KS; Watts M; Appleton DS; Lomas DJ; Jamieson N; Taylor KP; Coghill S; Brown MJ
    J Renin Angiotensin Aldosterone Syst; 2008 Jun; 9(2):103-6. PubMed ID: 18584586
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effect of diazoxide on blood pressure, PRA and plasma aldosterone in hypertensive patients (author's transl)].
    Mantero F; Perini A; Armanini D; Gion M; Opocher G; Boscaro M
    G Ital Cardiol; 1976; 6(7):1246-53. PubMed ID: 1010235
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnosis under random conditions of all disorders of the renin-angiotensin-aldosterone axis, including primary hyperaldosteronism.
    McKenna TJ; Sequeira SJ; Heffernan A; Chambers J; Cunningham S
    J Clin Endocrinol Metab; 1991 Nov; 73(5):952-7. PubMed ID: 1939533
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Variability in the renin/aldosterone profile under random and standardized sampling conditions in primary aldosteronism.
    Tanabe A; Naruse M; Takagi S; Tsuchiya K; Imaki T; Takano K
    J Clin Endocrinol Metab; 2003 Jun; 88(6):2489-94. PubMed ID: 12788844
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of primary aldosteronism among Asian hypertensive patients in Singapore.
    Loh KC; Koay ES; Khaw MC; Emmanuel SC; Young WF
    J Clin Endocrinol Metab; 2000 Aug; 85(8):2854-9. PubMed ID: 10946893
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alterations of calcium metabolism and of parathyroid function in primary aldosteronism, and their reversal by spironolactone or by surgical removal of aldosterone-producing adenomas.
    Rossi E; Sani C; Perazzoli F; Casoli MC; Negro A; Dotti C
    Am J Hypertens; 1995 Sep; 8(9):884-93. PubMed ID: 8541003
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Primary hyperaldosteronism].
    van den Meiracker AH; Deinum J
    Ned Tijdschr Geneeskd; 2003 Aug; 147(33):1580-5. PubMed ID: 12951726
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Primary hyperaldosteronism: a missed diagnosis in 'essential hypertensives'?
    Brown MA; Cramp HA; Zammit VC; Whitworth JA
    Aust N Z J Med; 1996 Aug; 26(4):533-8. PubMed ID: 8873937
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Abnormally sustained aldosterone secretion during salt loading in patients with various forms of benign hypertension; relation to plasma renin activity.
    Collins RD; Weinberger MH; Dowdy AJ; Nokes GW; Gonzales CM; Luetscher JA
    J Clin Invest; 1970 Jul; 49(7):1415-26. PubMed ID: 4317384
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Urinary aldosterone-to-active-renin ratio: a useful tool for predicting resolution of hypertension after adrenalectomy in patients with aldosterone-producing adenomas.
    Mourad JJ; Girerd X; Milliez P; Lopez-Sublet M; Lejeune S; Safar ME
    Am J Hypertens; 2008 Jul; 21(7):742-7. PubMed ID: 18443567
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Primary aldosteronism -- screening, diagnosis and therapy.
    Horký K; Gregorová I; Vancura J; Silinková-Málková E; Hradec E
    Cor Vasa; 1981; 23(4):265-79. PubMed ID: 7028394
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Severity of hypertension in familial hyperaldosteronism type I: relationship to gender and degree of biochemical disturbance.
    Stowasser M; Bachmann AW; Huggard PR; Rossetti TR; Gordon RD
    J Clin Endocrinol Metab; 2000 Jun; 85(6):2160-6. PubMed ID: 10852446
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [High prevalence of undiagnosed primary hyperaldosteronism among patients with essential hypertension].
    Mosso L; Fardella C; Montero J; Rojas P; Sánchez O; Rojas V; Rojas A; Huete A; Soto J; Foradori A
    Rev Med Chil; 1999 Jul; 127(7):800-6. PubMed ID: 10668287
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A screening test to identify aldosterone-producing adenoma by measuring plasma renin activity. Results in hypertensive patients.
    Hiramatsu K; Yamada T; Yukimura Y; Komiya I; Ichikawa K; Ishihara M; Nagata H; Izumiyama T
    Arch Intern Med; 1981 Nov; 141(12):1589-93. PubMed ID: 7030245
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.